Watch and Bet Harness Racing at TwinSpires.com
harnessracing.com
The Horsenman and Fair World
  • News Archive
  • Racing Reports
    • Sire's Progeny
    • Dam's Progeny
    • Single Horse
    • Leading Sires
    • Racing Recap
  • Sale Reports
    • Sire's Progeny
    • Dam's Progeny
    • Single Horse
    • Leading Sires
    • Sales Results
    • Sales Info
  • Calendars
    • Stakes Schedule
    • Sales Schedule
  • Entries/Results
    • USTA Entries
    • USTA Results
    • SC Entries
    • SC Results
  • Programs
    • TrackMaster® PPs
  • Guide Directory
  • Magazine Info
    • Issue Highlights
    • New Subscriptions
    • Renewals
    • Address Change
    • Advertising Rates
    • Send A Letter
« »
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    
View all for this month

Click here for RSS

New EPO test used in ONT

Return Home
August 07, 2006 Send To A Friend  | Print View

The Pennsylvania Equine Toxicology and Research Laboratory recently proved it deserves its number one ranking by being the first laboratory in the world to confirm the actual presence (not just the antibodies resulting from the use) of the drug erythropoietin (EPO), or Darbepoetin-Alfa, in the horse. The Pennsylvania laboratory was able to confirm laboratory readings from an ELISA test conducted in a Toronto laboratory on three racehorses in Ontario, which resulted in a lengthy suspension for the trainer of the horses by the Ontario Racing Commission.

“We first were able to extract the protein-based drug (EPO) from plasma, through the work of a team led by Dr. Eric Birks,” Dr. Lawrence Soma said. He is the equine research director at the New Bolton Center of the University of Pennsylvania School of Veterinary Medicine. Equine research conducted by Dr. Soma and Laboratory director Dr. Cornelius Uboh is supported by the Commission and contributions from horsemen.

“Then, Dr. Fuyu Guan, who works closely with Dr. Uboh, was able to develop a brand new method of breaking apart the protein of the human EPO molecules into smaller fractions (peptides), thus allowing the positive identification of the EPO itself using a very sensitive LC/MS/MS technology.

“Dr. Guan has been working on EPO and Darbepoetin-Alfa and conducting experiments with research horses that have been administered EPO, and thus he was able to use that information as a model. We have optimized the method, and today we are able to make the positive EPO/Darbepoetin-Alfa identification, and not just on the presence of antibodies that may be produced in the horse by the administration of human EPO to horses.” Pennsylvania Commission chairman Roy Wilt, commissioner Art Manuel, and executive secretary Anton Leppler, and the horsemen’s associations, applaud the cutting-edge work done by the lab, which puts Pennsylvania at the forefront of insuring the integrity of harness racing within its borders. (press release by Pennsylvania Harness Racing Commission)

« Back

Bookmark and Share
Home :: News Archive :: Racing Reports :: Sale Reports :: Calendars :: Guide Directory :: Contact The Staff
Advertising Rates & Information For: Horseman And Fair World Magazine :: HarnessRacing.com :: Harness Racing Weekend Preview
Website Design by eLink Design, Inc. A Lexington Web Design Company :: Hosted by Intelliwire, LLC, An Offsite Backup Company
Site contents may not be reproduced without the expressed written consent of the publisher.
© 2012 Horseman Publishing Co., Lexington KY, All Rights Reserved